Skip to main content
logo
Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.850
+0.010 (0.26%)
Sep 18, 2026, 4:08 PM HKT

HKG:2591 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Revenue
153.28131.51--
Revenue Growth
16.56%---
Gross Profit
123.24117.06--
Operating Income
-360.8-346.87-189.42-747.91
Net Income
-334.35-341.36-174.69-733.38
Earnings Per Share
-0.74-0.79-0.42-1.92
EPS Growth
----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Cash & Investments
1,0231,205796.85695.31
Total Debt
151.22166.269.946.59
Net Cash (Debt)
871.641,038786.95648.73
Net Cash Growth
-16.05%31.94%21.31%-
Net Cash Per Share
1.932.391.881.69

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-344.04-295.54-162.62-164.6
Capital Expenditures
-18.41-19.97-3.95-12.05
Free Cash Flow
-362.45-315.51-166.57-176.64
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Gross Margin
80.40%89.01%--
Operating Margin
-235.38%-263.76%--
Pretax Margin
-218.13%-259.57%--
Profit Margin
-218.13%-259.57%--
FCF Margin
-236.46%-239.91%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
PS Ratio
9.9495.64--